Need help finding what you are looking for?
Contact Us
PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1885405
PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1885405
Advanced Therapeutics Pharmaceutical Outsourcing Market - Global Advanced Therapeutics Pharmaceutical Outsourcing Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 -
PUBLISHED:
PAGES: 188 Pages
DELIVERY TIME: 2-5 business days
SELECT AN OPTION
The global Advanced Therapeutics Pharmaceutical Outsourcing Market is witnessing significant growth, driven by rising demand for specialized development, manufacturing, and clinical services. Valued at USD 8 billion in 2025, the market is projected to reach USD 11.1 billion by 2032, registering a CAGR of 4.8%. The increasing complexity of advanced therapeutic development and the need for cost-effective, high-quality outsourcing solutions are fueling market expansion. Pharmaceutical and biotechnology companies are increasingly leveraging external partners to accelerate product development timelines, enhance efficiency, and ensure compliance with stringent regulatory standards.
Market Insights
Advanced therapeutics, including gene therapy, cell therapy, and RNA-based therapies, are revolutionizing treatment approaches for chronic, rare, and life-threatening diseases. Outsourcing has become a critical component in the commercialization of these therapies, allowing companies to access specialized expertise and infrastructure without the need for extensive in-house capabilities.
Contract Development and Manufacturing Organizations (CDMOs) and Contract Research Organizations (CROs) are playing a pivotal role by providing comprehensive solutions, from preclinical research and clinical trials to commercial manufacturing and packaging. Oncology, neurology, cardiology, and infectious diseases are among the primary indications driving demand for outsourcing services.
Key Market Drivers
Several factors are contributing to the growth of the advanced therapeutics pharmaceutical outsourcing market:
- Expanding Adoption of Advanced Therapies: Increasing development of gene, cell, and RNA-based therapies is driving the need for specialized outsourcing services.
- Cost and Time Optimization: Outsourcing enables pharmaceutical companies to reduce operational costs and accelerate development cycles, making complex therapeutics more accessible.
- Collaborations and Partnerships: Strategic alliances between pharmaceutical companies and outsourcing providers enhance efficiency, compliance, and innovation.
- Technological Innovation: Advancements in bioprocessing, automation, and precision medicine are enhancing the scalability and reliability of outsourced services.
Business Opportunities
The market offers considerable opportunities for both established outsourcing providers and new entrants. End-to-end service offerings that cover development, clinical trials, and commercial manufacturing are in high demand. Companies investing in specialized therapies, advanced technologies, and regulatory support services can capture a larger market share. Emerging markets, particularly in Asia Pacific, present additional opportunities due to growing investments in biopharmaceutical infrastructure and favorable outsourcing environments.
Regional Analysis
- North America holds a dominant position, supported by a robust pharmaceutical industry, advanced research infrastructure, and high adoption of outsourced services.
- Europe demonstrates steady growth, aided by strong regulatory frameworks, clinical trial networks, and biomanufacturing investments.
- Asia Pacific is emerging as a high-growth market, driven by cost-efficient operations, government initiatives, and rising collaborations with global pharmaceutical companies.
- Latin America and Middle East & Africa are gradually expanding, primarily through clinical trial outsourcing and manufacturing partnerships.
Key Players
Leading companies shaping the advanced therapeutics pharmaceutical outsourcing landscape include:
- IQVIA (QuintilesIMS)
- Charles River Laboratories International, Inc.
- Catalent, Inc.
- Parexel International Corporation
- ICON plc
- PPD, Inc. (Thermo Fisher Scientific)
- LabCorp (Laboratory Corporation of America Holdings)
- Syneos Health
- WuXi AppTec
- Lonza Group
- Piramal Pharma Solutions
- SGS SA
- Evotec SE
- AGC Biologics (formerly CMC Biologics)
- Cytovance Biologics
- Others
Global Advanced Therapeutics Pharmaceutical Outsourcing Market Segmentation-
By Service Type
- Contract Development and Manufacturing Organizations (CDMOs)
- Contract Research Organizations (CROs)
By Indication
- Neurology
- Cardiology
- Oncology
- Infectious Diseases
- Others
By Therapy
- Gene Therapy
- Cell Therapy
- RNA-based Therapies
- Others
By Phases
- Clinical Services
- Preclinical Services
- Commercial Manufacturing and Packaging
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Table of Contents
1. Executive Summary
- 1.1. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Snapshot
- 1.2. Future Projections
- 1.3. Key Market Trends
- 1.4. Regional Snapshot, by Value, 2025
- 1.5. Analyst Recommendations
2. Market Overview
- 2.1. Market Definitions and Segmentations
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
- 2.3. Value Chain Analysis
- 2.4. COVID-19 Impact Analysis
- 2.5. Porter's Fiver Forces Analysis
- 2.6. Impact of Russia-Ukraine Conflict
- 2.7. PESTLE Analysis
- 2.8. Regulatory Analysis
- 2.9. Price Trend Analysis
- 2.9.1. Current Prices and Future Projections, 2024-2032
- 2.9.2. Price Impact Factors
3. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, 2019-2032
- 3.1. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Service Type, Value (US$ Bn), 2019-2032
- 3.1.1. Contract Development and Manufacturing Organizations (CDMOs)
- 3.1.2. Contract Research Organizations (CROs)
- 3.2. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Indication, Value (US$ Bn), 2019-2032
- 3.2.1. Neurology
- 3.2.2. Cardiology
- 3.2.3. Oncology
- 3.2.4. Infectious Diseases
- 3.2.5. Others
- 3.3. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Therapy, Value (US$ Bn), 2019-2032
- 3.3.1. Gene Therapy
- 3.3.2. Cell Therapy
- 3.3.3. RNA-based Therapies
- 3.3.4. Others
- 3.4. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Phases, Value (US$ Bn), 2019-2032
- 3.4.1. Clinical Services
- 3.4.2. Preclinical Services
- 3.4.3. Commercial Manufacturing and Packaging
- 3.5. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Region, Value (US$ Bn), 2019-2032
- 3.5.1. North America
- 3.5.2. Europe
- 3.5.3. Asia Pacific
- 3.5.4. Latin America
- 3.5.5. Middle East & Africa
4. North America Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, 2019-2032
- 4.1. North America Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Service Type, Value (US$ Bn), 2019-2032
- 4.1.1. Contract Development and Manufacturing Organizations (CDMOs)
- 4.1.2. Contract Research Organizations (CROs)
- 4.2. North America Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Indication, Value (US$ Bn), 2019-2032
- 4.2.1. Neurology
- 4.2.2. Cardiology
- 4.2.3. Oncology
- 4.2.4. Infectious Diseases
- 4.2.5. Others
- 4.3. North America Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Therapy, Value (US$ Bn), 2019-2032
- 4.3.1. Gene Therapy
- 4.3.2. Cell Therapy
- 4.3.3. RNA-based Therapies
- 4.3.4. Others
- 4.4. North America Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Phases, Value (US$ Bn), 2019-2032
- 4.4.1. Clinical Services
- 4.4.2. Preclinical Services
- 4.4.3. Commercial Manufacturing and Packaging
- 4.5. North America Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Country, Value (US$ Bn), 2019-2032
- 4.5.1. U.S. Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Service Type, 2019-2032
- 4.5.2. U.S. Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Indication, 2019-2032
- 4.5.3. U.S. Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Therapy, 2019-2032
- 4.5.4. U.S. Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Phases, 2019-2032
- 4.5.5. Canada Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Service Type, 2019-2032
- 4.5.6. Canada Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Indication, 2019-2032
- 4.5.7. Canada Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Therapy, 2019-2032
- 4.5.8. Canada Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Phases, 2019-2032
- 4.6. BPS Analysis/Market Attractiveness Analysis
5. Europe Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, 2019-2032
- 5.1. Europe Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Service Type, Value (US$ Bn), 2019-2032
- 5.1.1. Contract Development and Manufacturing Organizations (CDMOs)
- 5.1.2. Contract Research Organizations (CROs)
- 5.2. Europe Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Indication, Value (US$ Bn), 2019-2032
- 5.2.1. Neurology
- 5.2.2. Cardiology
- 5.2.3. Oncology
- 5.2.4. Infectious Diseases
- 5.2.5. Others
- 5.3. Europe Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Therapy, Value (US$ Bn), 2019-2032
- 5.3.1. Gene Therapy
- 5.3.2. Cell Therapy
- 5.3.3. RNA-based Therapies
- 5.3.4. Others
- 5.4. Europe Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Phases, Value (US$ Bn), 2019-2032
- 5.4.1. Clinical Services
- 5.4.2. Preclinical Services
- 5.4.3. Commercial Manufacturing and Packaging
- 5.5. Europe Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Country, Value (US$ Bn), 2019-2032
- 5.5.1. Germany Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Service Type, 2019-2032
- 5.5.2. Germany Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Indication, 2019-2032
- 5.5.3. Germany Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Therapy, 2019-2032
- 5.5.4. Germany Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Phases, 2019-2032
- 5.5.5. Italy Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Service Type, 2019-2032
- 5.5.6. Italy Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Indication, 2019-2032
- 5.5.7. Italy Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Therapy, 2019-2032
- 5.5.8. Italy Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Phases, 2019-2032
- 5.5.9. France Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Service Type, 2019-2032
- 5.5.10. France Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Indication, 2019-2032
- 5.5.11. France Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Therapy, 2019-2032
- 5.5.12. France Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Phases, 2019-2032
- 5.5.13. U.K. Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Service Type, 2019-2032
- 5.5.14. U.K. Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Indication, 2019-2032
- 5.5.15. U.K. Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Therapy, 2019-2032
- 5.5.16. U.K. Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Phases, 2019-2032
- 5.5.17. Spain Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Service Type, 2019-2032
- 5.5.18. Spain Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Indication, 2019-2032
- 5.5.19. Spain Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Therapy, 2019-2032
- 5.5.20. Spain Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Phases, 2019-2032
- 5.5.21. Russia Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Service Type, 2019-2032
- 5.5.22. Russia Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Indication, 2019-2032
- 5.5.23. Russia Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Therapy, 2019-2032
- 5.5.24. Russia Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Phases, 2019-2032
- 5.5.25. Rest of Europe Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Service Type, 2019-2032
- 5.5.26. Rest of Europe Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Indication, 2019-2032
- 5.5.27. Rest of Europe Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Therapy, 2019-2032
- 5.5.28. Rest of Europe Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Phases, 2019-2032
- 5.6. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, 2019-2032
- 6.1. Asia Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Service Type, Value (US$ Bn), 2019-2032
- 6.1.1. Contract Development and Manufacturing Organizations (CDMOs)
- 6.1.2. Contract Research Organizations (CROs)
- 6.2. Asia Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Indication, Value (US$ Bn), 2019-2032
- 6.2.1. Neurology
- 6.2.2. Cardiology
- 6.2.3. Oncology
- 6.2.4. Infectious Diseases
- 6.2.5. Others
- 6.3. Asia Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Therapy, Value (US$ Bn), 2019-2032
- 6.3.1. Gene Therapy
- 6.3.2. Cell Therapy
- 6.3.3. RNA-based Therapies
- 6.3.4. Others
- 6.4. Asia Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Phases, Value (US$ Bn), 2019-2032
- 6.4.1. Clinical Services
- 6.4.2. Preclinical Services
- 6.4.3. Commercial Manufacturing and Packaging
- 6.5. Asia Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Country, Value (US$ Bn), 2019-2032
- 6.5.1. China Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Service Type, 2019-2032
- 6.5.2. China Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Indication, 2019-2032
- 6.5.3. China Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Therapy, 2019-2032
- 6.5.4. China Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Phases, 2019-2032
- 6.5.5. Japan Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Service Type, 2019-2032
- 6.5.6. Japan Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Indication, 2019-2032
- 6.5.7. Japan Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Therapy, 2019-2032
- 6.5.8. Japan Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Phases, 2019-2032
- 6.5.9. South Korea Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Service Type, 2019-2032
- 6.5.10. South Korea Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Indication, 2019-2032
- 6.5.11. South Korea Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Therapy, 2019-2032
- 6.5.12. South Korea Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Phases, 2019-2032
- 6.5.13. India Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Service Type, 2019-2032
- 6.5.14. India Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Indication, 2019-2032
- 6.5.15. India Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Therapy, 2019-2032
- 6.5.16. India Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Phases, 2019-2032
- 6.5.17. Southeast Asia Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Service Type, 2019-2032
- 6.5.18. Southeast Asia Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Indication, 2019-2032
- 6.5.19. Southeast Asia Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Therapy, 2019-2032
- 6.5.20. Southeast Asia Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Phases, 2019-2032
- 6.5.21. Rest of SAO Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Service Type, 2019-2032
- 6.5.22. Rest of SAO Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Indication, 2019-2032
- 6.5.23. Rest of SAO Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Therapy, 2019-2032
- 6.5.24. Rest of SAO Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Phases, 2019-2032
- 6.6. BPS Analysis/Market Attractiveness Analysis
7. Latin America Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, 2019-2032
- 7.1. Latin America Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Service Type, Value (US$ Bn), 2019-2032
- 7.1.1. Contract Development and Manufacturing Organizations (CDMOs)
- 7.1.2. Contract Research Organizations (CROs)
- 7.2. Latin America Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Indication, Value (US$ Bn), 2019-2032
- 7.2.1. Neurology
- 7.2.2. Cardiology
- 7.2.3. Oncology
- 7.2.4. Infectious Diseases
- 7.2.5. Others
- 7.3. Latin America Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Therapy, Value (US$ Bn), 2019-2032
- 7.3.1. Gene Therapy
- 7.3.2. Cell Therapy
- 7.3.3. RNA-based Therapies
- 7.3.4. Others
- 7.4. Latin America Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Phases, Value (US$ Bn), 2019-2032
- 7.4.1. Clinical Services
- 7.4.2. Preclinical Services
- 7.4.3. Commercial Manufacturing and Packaging
- 7.5. Latin America Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Country, Value (US$ Bn), 2019-2032
- 7.5.1. Brazil Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Service Type, 2019-2032
- 7.5.2. Brazil Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Indication, 2019-2032
- 7.5.3. Brazil Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Therapy, 2019-2032
- 7.5.4. Brazil Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Phases, 2019-2032
- 7.5.5. Mexico Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Service Type, 2019-2032
- 7.5.6. Mexico Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Indication, 2019-2032
- 7.5.7. Mexico Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Therapy, 2019-2032
- 7.5.8. Mexico Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Phases, 2019-2032
- 7.5.9. Argentina Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Service Type, 2019-2032
- 7.5.10. Argentina Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Indication, 2019-2032
- 7.5.11. Argentina Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Therapy, 2019-2032
- 7.5.12. Argentina Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Phases, 2019-2032
- 7.5.13. Rest of LATAM Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Service Type, 2019-2032
- 7.5.14. Rest of LATAM Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Indication, 2019-2032
- 7.5.15. Rest of LATAM Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Therapy, 2019-2032
- 7.5.16. Rest of LATAM Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Phases, 2019-2032
- 7.6. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, 2019-2032
- 8.1. Middle East & Africa Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Service Type, Value (US$ Bn), 2019-2032
- 8.1.1. Contract Development and Manufacturing Organizations (CDMOs)
- 8.1.2. Contract Research Organizations (CROs)
- 8.2. Middle East & Africa Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Indication, Value (US$ Bn), 2019-2032
- 8.2.1. Neurology
- 8.2.2. Cardiology
- 8.2.3. Oncology
- 8.2.4. Infectious Diseases
- 8.2.5. Others
- 8.3. Middle East & Africa Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Therapy, Value (US$ Bn), 2019-2032
- 8.3.1. Gene Therapy
- 8.3.2. Cell Therapy
- 8.3.3. RNA-based Therapies
- 8.3.4. Others
- 8.4. Middle East & Africa Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Phases, Value (US$ Bn), 2019-2032
- 8.4.1. Clinical Services
- 8.4.2. Preclinical Services
- 8.4.3. Commercial Manufacturing and Packaging
- 8.5. Middle East & Africa Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Country, Value (US$ Bn), 2019-2032
- 8.5.1. GCC Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Service Type, 2019-2032
- 8.5.2. GCC Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Indication, 2019-2032
- 8.5.3. GCC Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Therapy, 2019-2032
- 8.5.4. GCC Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Phases, 2019-2032
- 8.5.5. South Africa Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Service Type, 2019-2032
- 8.5.6. South Africa Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Indication, 2019-2032
- 8.5.7. South Africa Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Therapy, 2019-2032
- 8.5.8. South Africa Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Phases, 2019-2032
- 8.5.9. Egypt Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Service Type, 2019-2032
- 8.5.10. Egypt Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Indication, 2019-2032
- 8.5.11. Egypt Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Therapy, 2019-2032
- 8.5.12. Egypt Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Phases, 2019-2032
- 8.5.13. Nigeria Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Service Type, 2019-2032
- 8.5.14. Nigeria Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Indication, 2019-2032
- 8.5.15. Nigeria Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Therapy, 2019-2032
- 8.5.16. Nigeria Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Phases, 2019-2032
- 8.5.17. Rest of Middle East Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Service Type, 2019-2032
- 8.5.18. Rest of Middle East Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Indication, 2019-2032
- 8.5.19. Rest of Middle East Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Therapy, 2019-2032
- 8.5.20. Rest of Middle East Advanced Therapeutics Pharmaceutical Outsourcing Market Outlook, by Phases, 2019-2032
- 8.6. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
- 9.1. Company Vs Segment Heatmap
- 9.2. Company Market Share Analysis, 2024
- 9.3. Competitive Dashboard
- 9.4. Company Profiles
- 9.4.1. IQVIA (QuintilesIMS)
- 9.4.1.1. Company Overview
- 9.4.1.2. Product Portfolio
- 9.4.1.3. Financial Overview
- 9.4.1.4. Business Strategies and Developments
- 9.4.2. Charles River Laboratories International, Inc.
- 9.4.2.1. Company Overview
- 9.4.2.2. Product Portfolio
- 9.4.2.3. Financial Overview
- 9.4.2.4. Business Strategies and Developments
- 9.4.3. Catalent, Inc.
- 9.4.3.1. Company Overview
- 9.4.3.2. Product Portfolio
- 9.4.3.3. Financial Overview
- 9.4.3.4. Business Strategies and Developments
- 9.4.4. Parexel International Corporation
- 9.4.4.1. Company Overview
- 9.4.4.2. Product Portfolio
- 9.4.4.3. Financial Overview
- 9.4.4.4. Business Strategies and Developments
- 9.4.5. ICON plc
- 9.4.5.1. Company Overview
- 9.4.5.2. Product Portfolio
- 9.4.5.3. Financial Overview
- 9.4.5.4. Business Strategies and Developments
- 9.4.6. PPD, Inc. (Thermo Fisher Scientific)
- 9.4.6.1. Company Overview
- 9.4.6.2. Product Portfolio
- 9.4.6.3. Financial Overview
- 9.4.6.4. Business Strategies and Developments
- 9.4.7. LabCorp (Laboratory Corporation of America Holdings)
- 9.4.7.1. Company Overview
- 9.4.7.2. Product Portfolio
- 9.4.7.3. Financial Overview
- 9.4.7.4. Business Strategies and Developments
- 9.4.8. Syneos Health
- 9.4.8.1. Company Overview
- 9.4.8.2. Product Portfolio
- 9.4.8.3. Financial Overview
- 9.4.8.4. Business Strategies and Developments
- 9.4.9. WuXi AppTec
- 9.4.9.1. Company Overview
- 9.4.9.2. Product Portfolio
- 9.4.9.3. Financial Overview
- 9.4.9.4. Business Strategies and Developments
- 9.4.10. Lonza Group
- 9.4.10.1. Company Overview
- 9.4.10.2. Product Portfolio
- 9.4.10.3. Financial Overview
- 9.4.10.4. Business Strategies and Developments
- 9.4.1. IQVIA (QuintilesIMS)
10. Appendix
- 10.1. Research Methodology
- 10.2. Report Assumptions
- 10.3. Acronyms and Abbreviations
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.